Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

564 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antibodies in the therapy of colon cancer.
Welt S, Ritter G. Welt S, et al. Semin Oncol. 1999 Dec;26(6):683-90. Semin Oncol. 1999. PMID: 10606261 Review.
The main reasons for this are based on the inherent pharmacokinetics and physiology of IgG, the immunoglobulin G molecule. Factors that may limit targeting potential include accessibility of tumor antigen, and antibody affinity, molecular size, and metabolism. ...
The main reasons for this are based on the inherent pharmacokinetics and physiology of IgG, the immunoglobulin G molecule. Factors th …
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
Livingston PO, Wong GY, Adluri S, Tao Y, Padavan M, Parente R, Hanlon C, Calves MJ, Helling F, Ritter G, et al. Livingston PO, et al. J Clin Oncol. 1994 May;12(5):1036-44. doi: 10.1200/JCO.1994.12.5.1036. J Clin Oncol. 1994. PMID: 8164027 Clinical Trial.
Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G, Fortunato SR, Cohen L, Noguchi Y, Bernard EM, Stockert E, Old LJ. Ritter G, et al. Int J Cancer. 1996 Apr 10;66(2):184-90. doi: 10.1002/(SICI)1097-0215(19960410)66:2<184::AID-IJC8>3.0.CO;2-Z. Int J Cancer. 1996. PMID: 8603809
Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.
Ritter G, Cohen LS, Nice EC, Catimel B, Burgess AW, Moritz RL, Ji H, Heath JK, White SJ, Welt S, Old LJ, Simpson RJ. Ritter G, et al. Biochem Biophys Res Commun. 1997 Jul 30;236(3):682-6. doi: 10.1006/bbrc.1997.6966. Biochem Biophys Res Commun. 1997. PMID: 9245713
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Kitamura K, Livingston PO, Fortunato SR, Stockert E, Helling F, Ritter G, Oettgen HF, Old LJ. Kitamura K, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2805-9. doi: 10.1073/pnas.92.7.2805. Proc Natl Acad Sci U S A. 1995. PMID: 7708728 Free PMC article.
Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.
Ritter G, Ritter-Boosfeld E, Adluri R, Calves M, Ren S, Yu RK, Oettgen HF, Old LJ, Livingston PO. Ritter G, et al. Int J Cancer. 1995 Sep 15;62(6):668-72. doi: 10.1002/ijc.2910620604. Int J Cancer. 1995. PMID: 7558412
Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3.
Ritter G, Boosfeld E, Markstein E, Yu RK, Ren SL, Stallcup WB, Oettgen HF, Old LJ, Livingston PO. Ritter G, et al. Cancer Res. 1990 Mar 1;50(5):1403-10. Cancer Res. 1990. PMID: 2302705
564 results
Jump to page
Feedback